1 |
Siege RL, Miller KD, Jemal, A, Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 2020; 70(1), 7-30.
DOI
|
2 |
Rawla P, Epidemiology of Prostate Cancer. World Journal of Oncology, 2019; 10(2), 63-89.
DOI
|
3 |
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, Global cancer statistics. CA: A Cancer Journal for Clinicians, 2011; 61(2), 69-90.
DOI
|
4 |
O'Neill D, Jones D, Wade M, Grey J, Nakjang S, Guo, W, et al., Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy. Oncotarget, 2015; 6(28), 26029-26040.
DOI
|
5 |
Kim BH, Lee SY, Cho HJ, You SN, Kim YJ, Park YM, et al., Biotransformation of Korean Panax ginseng by Pectinex. Biological and Pharmaceutical Bulletin 2006;29(12),2472-2478.
DOI
|
6 |
Baik IH, Kim KH, Lee KA, Antioxidant, Anti-Inflammatory and Antithrombotic Effects of Ginsenoside Compound K Enriched Extract Derived from Ginseng Sprouts. Molecules, 2021;26(13),4102.
DOI
|
7 |
Oh J, Kim JS, Compound K derived from ginseng: neuroprotection and cognitive improvement, Food & Function, 2016;7(11),4506-4515.
DOI
|
8 |
Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, et al., Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biological and Pharmaceutical Bulletin, 2005;28(4),652-6.
DOI
|
9 |
Kim DY, Yuan HD, Chung IK, Chung SH, Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells, Journal of Agricultural and Food Chemistry, 2009;57(4), 1532-1537.
DOI
|
10 |
Kim SH, Kim KY, Yu SN, Park SK, Kwak IS, Rhee MS, et al., Regulation of Pipernonaline on Biological Functions of Human Prostate Cancer Cells Based on Microarray Analysis, Journal of Life Science, 2012;22(11), 1552~1557.
DOI
|
11 |
Li S, Becich MJ, Gilbertson J, Microarray data mining using gene ontology. Stud. Health Technol. Inform. 2004;107,778-782.
|
12 |
Yao H, Wan JY, Zeng J, Huang WH, Sava-Segal C, Li L, et al., Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer, Oncology Letters, 2018;15(6),8339-8348.
|
13 |
Bray F, erlay, J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018; 68(6), 394-424.
DOI
|
14 |
Liu Y, Levine B, Autosis and autophagic cell death: the dark side of autophagy. Cell Death & Differentiation, 2015; 22(3), 367-376.
DOI
|
15 |
Zhou L, Chen L, Zeng X, Liao J, Ouyang D, Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis. Toxicology and Applied Pharmacology, 2020;386,114829.
DOI
|
16 |
Chen XJ, Liu WJ, Wen ML, Liang H, Wu SM, Zhu YZ, Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats, Scientific Reports, 2017;7,41144.
DOI
|
17 |
Kim MS, Lee KT, Iseli TJ, Hoy AJ, George J, Grewal T, et al., Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. Liver International, 2013;33(10),1583-93.
DOI
|
18 |
Lammers G, Gilissen C, Nillesen ST, Uijtdewilligen PJ, Wismans RG, Veltman JA, et al., High density gene expression microarrays and gene ontology analysis for identifying processes in implanted tissue engineering constructs. Biomaterials 2010;31,8299-8312.
DOI
|
19 |
Kim EH, Kim W, An Insight into Ginsenoside Metabolite Compound K as a Potential Tool for Skin Disorder, Evidence-Based Complementary and Alternative Medicine, 2018;2018,8075870.
DOI
|